Octant

Octant doubles its initial investment in Zymergen's Automation Technology to significantly increase the scale and throughput of its drug discovery platformEMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (

Octant recently announced it raised $80 million in funding. These are the details.

Octant Bio's synthetic biology approach to drug discovery is making progress, and the preclinical biotech has raised $80 million in Series B financing to continue the journey. The company added Bristol Myers Squibb as an investor and collaborator in the s

Today, Octant, a therapeutics company integrating novel high-throughput experimental technologies with computation to solve complex challenges in drug discovery, announced the appointment of Mark Murcko as Strategic Advisor and Board Member. Murcko brings

The octant was the dominant tool for maritime navigation in the 18th century because it enabled sailors to chart an accurate course, even in pitching and rolling seas. Like seafaring, drug discovery is, at its core, exploratory. The primary objective in t

In my lab, I run a number of different flavors of Kubernetes. Some of them I deploy via kubeadm. Others I have provisioned by VMware PKS. Some of these can access the outside world, while others are secured. Sometimes it is difficult to figure out the rel